Publications 2018

Clementy, N., Garcia, B., André, C., Bisson, A., Benhenda, N., Pierre, B., Bernard, A., Fauchier, L., Piver, E., Babuty, D., 2018b. Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure. PLoS ONE 13, e0201517. https://doi.org/10.1371/journal.pone.0201517
Clementy, N., Piver, E., Bisson, A., Andre, C., Bernard, A., Pierre, B., Fauchier, L., Babuty, D., 2018c. Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications. Int J Mol Sci 19. https://doi.org/10.3390/ijms19040976
Dutta, S., Lopez Charcas, O., Tanner, S., Gradek, F., Driffort, V., Roger, S., Selander, K., Velu, S.E., Brouillette, W., 2018. Discovery and evaluation of nNav1.5 sodium channel blockers with potent cell invasion inhibitory activity in breast cancer cells. Bioorg. Med. Chem. 26, 2428–2436. https://doi.org/10.1016/j.bmc.2018.04.003
Gatault, P., Al-Hajj, S., Noble, J., Chevallier, E., Piollet, M., Forconi, C., Gaudy-Graffin, C., Thibault, G., Miquelestorena-Standley, E., Halimi, J.-M., Büchler, M., Lemoine, R., Baron, C., 2018. CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells. Am. J. Transplant. 18, 1904–1913. https://doi.org/10.1111/ajt.14672
Greco, M.R., Bon, E., Rubino, R., Guerra, L., Bernabe-Garcia, M., Cannone, S., Cayuela, M.-L., Ciaccia, L., Marionneau-Lambot, S., Oullier, T., Fromont, G., Guibon, R., Roger, S., Reshkin, S.J., Cardone, R.A., 2019. Phosphorylation of NHERF1 S279 and S301 differentially regulates breast cancer cell phenotype and metastatic organotropism. Biochim Biophys Acta Mol Basis Dis 1865, 26–37. https://doi.org/10.1016/j.bbadis.2018.10.017
Lefort, C., Benoist, L., Chadet, S., Piollet, M., Heraud, A., Babuty, D., Baron, C., Ivanes, F., Angoulvant, D., 2018. Stimulation of P2Y11 receptor modulates cardiac fibroblasts secretome toward immunomodulatory and protective roles after Hypoxia/Reoxygenation injury. J. Mol. Cell. Cardiol. 121, 212–222. https://doi.org/10.1016/j.yjmcc.2018.07.245
Moussata, D., Allez, M., Cazals-Hatem, D., Treton, X., Laharie, D., Reimund, J.-M., Bertheau, P., Bourreille, A., Lavergne-Slove, A., Brixi, H., Branche, J., Gornet, J.-M., Stefanescu, C., Moreau, J., Marteau, P., Pelletier, A.-L., Carbonnel, F., Seksik, P., Simon, M., Fléjou, J.-F., Colombel, J.-F., Charlois, A.-L., Roblin, X., Nancey, S., Bouhnik, Y., Berger, F., Flourié, B., the GETAID, 2018. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut 67, 616–624. https://doi.org/10.1136/gutjnl-2016-311892
Ternant, D., Azzopardi, N., Raoul, W., Bejan-Angoulvant, T., Paintaud, G., 2019. Influence of Antigen Mass on the Pharmacokinetics of Therapeutic Antibodies in Humans. Clin Pharmacokinet 58, 169–187. https://doi.org/10.1007/s40262-018-0680-3
Ternant, D., Passot, C., Aubourg, A., Goupille, P., Desvignes, C., Picon, L., Lecomte, T., Mulleman, D., Paintaud, G., 2018. Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration. Clin Pharmacokinet 57, 1173–1184. https://doi.org/10.1007/s40262-017-0621-6
Wei, L., Syed Mortadza, S.A., Yan, J., Zhang, L., Wang, L., Yin, Y., Li, C., Chalon, S., Emond, P., Belzung, C., Li, D., Lu, C., Roger, S., Jiang, L.-H., 2018. ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics. Neurosci Biobehav Rev 87, 192–205. https://doi.org/10.1016/j.neubiorev.2018.02.005